Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Clinical trial NCT04180371 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04180371
Sponsor: BicycleTx Limited
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Historically Known for High EphA2 Expression Urothelial Cancer Ovarian Cancer Non-small Cell Lung Cancer Head and Neck Cancer Triple Negative Breast Cancer Gastric/Upper Gastrointestinal Cancer

Start date: 2019-11-07
Primary completion: 2026-07-31
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.